MyFinsight
Home
Blog
About
Raymond_logo-svg
RAYMOND JAMES FINANCIAL INC (RJF)
Raymond_logo-svg
RAYMOND JAMES FINANCIAL INC (RJF)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$308M
Unit: Million (M) dollars
Positive Cash Flow Breakdown
Increase in bank deposits
Net income
Proceeds from sales of loans hel...
Others
Negative Cash Flow Breakdown
Increase in bank loans, net
Collateralized agreements, net o...
Brokerage client receivables and...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net revenues
-
-
-
1,814
Total non-interest expenses
-
-
-
263
Pre-tax income before equity in undistributed net income of subsidiaries
-
-
-
1,551
Income tax benefit
-
-
-
-83
Income before equity in undistributed net income of subsidiaries
-
-
-
1,634
Equity in undistributed net income of subsidiaries
-
-
-
501
Net income
595
544
563
604
Depreciation and amortization
55
50
49
52
Deferred income taxes, net
17
77
35
-48
Premium and discount amortization on available-for-sale securities and bank loans and net unrealized gains/losses on other investments
5
4
-1
0
Provisions for credit losses and legal and regulatory matters, net
-24
19
2
15
Share-based compensation expense
50
54
79
55
Unrealized gains on corporate-owned life insurance policies, net of expenses
162
-32
22
65
Other
-7
-11
-16
-16
Collateralized agreements, net of collateralized financings
871
-393
272
-470
Loans (provided to) financial advisors, net of repayments
-
-
-
134
Loans provided to financial advisors, net of repayments
185
130
156
-
Brokerage client receivables and other receivables, net
660
685
-206
-64
Trading instruments, net
-41
181
-119
222
Derivative instruments, net
-83
-37
27
-15
Other assets
-112
-10
54
-41
Brokerage client payables and other payables
288
616
5
-324
Accrued compensation, commissions and benefits
407
166
-659
388
Proceeds from sales of securitizations and loans held for sale, net of purchases and originations of loans held for sale
-6
-90
-105
131
Net cash provided by operating activities
-246
1,099
-10
796
Increase in bank loans, net
1,937
1,435
2,137
1,667
Proceeds from sales of loans held for investment
499
35
81
27
Purchases of available-for-sale securities
538
343
66
102
Available-for-sale securities maturations, repayments and redemptions
389
575
360
445
Proceeds from sales of available-for-sale securities
40
0
0
0
Cash paid for acquisitions, net of cash acquired
392
92
-
-
Additions to property and equipment
62
45
46
44
Sales/(purchases) of federal reserve bank (frb) and federal home loan bank (fhlb) stock, net
-
-
-
-3
Renewable energy tax credit equity investments
-
-
-
20
Sales of federal reserve bank (frb) and federal home loan bank (fhlb) stock
0
0
-
-
Sales/(purchases) of other investments, net
-
-
-
73
Equity method investments, net of distributions received
86
-
-
-
Other investing activities, net
5
32
57
-8
Net cash used in investing activities
-2,092
-1,337
-1,865
-1,423
Increase in bank deposits
896
2,271
1,255
1,648
Repurchases of common stock and share-based awards withheld for payment of withholding tax requirements
401
405
513
353
Dividends on common and preferred stock
105
109
112
102
Employee stock purchases and exercise of stock options
10
14
9
5
Redemption of preferred stock
0
81
-
0
Proceeds from senior notes issuance, net of debt issuance costs paid
-
-
-
1,480
Redemption of subordinated notes
-
-
-
98
Proceeds from fhlb advances
100
50
250
750
Repayments of fhlb advances
100
50
250
50
Proceeds from short-term borrowings
250
-
-
-
Other financing, net
-1
0
-10
2
Net cash provided by/(used in) financing activities
649
1,690
629
2,532
Effect of exchange rate changes on cash and cash equivalents, including those segregated for regulatory purposes
-21
-58
29
-83
Net decrease in cash and cash equivalents, including those segregated for regulatory purposes and restricted cash
-1,710
1,394
-1,217
1,822
Cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at beginning of year
13,570
13,570
14,787
13,580
Cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at end of period
13,254
14,964
13,570
14,787
Cash and cash equivalents
9,977
11,219
9,890
11,389
Cash and cash equivalents segregated for regulatory purposes and restricted cash
3,277
3,745
3,680
3,398
Total cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at end of period
13,254
14,964
13,570
14,787
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Increase in bank deposits
$896M
(5.91%↑ Y/Y)
Proceeds from short-term
borrowings
$250M
Proceeds from fhlb
advances
$100M
(-66.67%↓ Y/Y)
Employee stock purchases
and exercise of...
$10M
(42.86%↑ Y/Y)
Net cash provided
by/(used in) financing...
$649M
(122.26%↑ Y/Y)
Canceled cashflow
$607M
Net decrease in cash
and cash...
-$1,710M
(-1301.64%↓ Y/Y)
Canceled cashflow
$649M
Proceeds from sales of
loans held for...
$499M
(269.63%↑ Y/Y)
Available-for-sale securities
maturations, repayments and...
$389M
(-25.48%↓ Y/Y)
Proceeds from sales of
available-for-sale securities
$40M
Net income
$595M
(36.47%↑ Y/Y)
Accrued compensation,
commissions and benefits
$407M
(36.58%↑ Y/Y)
Brokerage client payables
and other payables
$288M
(-1.71%↓ Y/Y)
Other assets
-$112M
(-103.64%↓ Y/Y)
Derivative instruments,
net
-$83M
(-197.65%↓ Y/Y)
Depreciation and
amortization
$55M
(12.24%↑ Y/Y)
Share-based compensation
expense
$50M
(-3.85%↓ Y/Y)
Trading instruments,
net
-$41M
(71.92%↑ Y/Y)
Deferred income taxes,
net
$17M
(134.00%↑ Y/Y)
Other
-$7M
(-250.00%↓ Y/Y)
Proceeds from sales of
securitizations and loans held...
-$6M
(-110.53%↓ Y/Y)
Repurchases of common stock
and share-based...
$401M
(-11.87%↓ Y/Y)
Dividends on common and
preferred stock
$105M
(1.94%↑ Y/Y)
Repayments of fhlb advances
$100M
(-66.67%↓ Y/Y)
Other financing, net
-$1M
(66.67%↑ Y/Y)
Net cash used in
investing activities
-$2,092M
(-60.68%↓ Y/Y)
Canceled cashflow
$928M
Net cash provided by
operating activities
-$246M
(-135.60%↓ Y/Y)
Effect of exchange rate
changes on cash and cash...
-$21M
(-110.66%↓ Y/Y)
Canceled cashflow
$1,661M
Increase in bank loans,
net
$1,937M
(13.27%↑ Y/Y)
Purchases of
available-for-sale securities
$538M
(198.89%↑ Y/Y)
Cash paid for
acquisitions, net of cash...
$392M
Equity method
investments, net of...
$86M
Additions to property and
equipment
$62M
(8.77%↑ Y/Y)
Other investing
activities, net
$5M
(-54.55%↓ Y/Y)
Collateralized agreements, net
of collateralized...
$871M
(198.29%↑ Y/Y)
Brokerage client
receivables and other...
$660M
(2100.00%↑ Y/Y)
Loans provided to
financial advisors, net of...
$185M
Unrealized gains on
corporate-owned life insurance...
$162M
(63.64%↑ Y/Y)
Provisions for credit
losses and legal and...
-$24M
(-128.92%↓ Y/Y)
Premium and discount
amortization on...
$5M
(-72.22%↓ Y/Y)
Buy us a coffee